Hirai Risako, Kei Motoki, Uesawa Yoshihiro
Department of Medical Molecular Informatics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.
Department of Pharmacy, Tokyo Women's Medical University Adachi Medical Center, 4-33-1 Kohoku, Adachi-ku, Tokyo 123-8558, Japan.
J Clin Med. 2025 Feb 20;14(5):1410. doi: 10.3390/jcm14051410.
: There exist multiple opioid-based treatments in palliative care, each with distinct side effect profiles. When adverse events occur, switching opioids can help maintain effective pain management. However, owing to limited clinical evidence, no comprehensive guidelines exist for opioid switching. This study employed the Side Effect Resource (SIDER) database, which aggregates adverse event data from clinical trials and package inserts, to analyze the side effects of five commonly used "strong opioids" in palliative care in Japan, namely morphine, fentanyl, oxycodone, hydromorphone, and tapentadol. : Data on the names and incidence of adverse events for each opioid were extracted from SIDER 4.1, developed by the Max Delbrück Center for Molecular Medicine. Cluster analysis and principal component analysis were performed to interpret the data. : The key side effects of opioids were nausea, vomiting, constipation, and drowsiness. Fentanyl was more frequently associated with nausea and vomiting but less frequently with constipation and drowsiness. Tapentadol caused nausea relatively more frequently and constipation less frequently. Oxycodone was prominently linked to drowsiness, whereas morphine was frequently associated with constipation and drowsiness. Hydromorphone was associated with higher rates of constipation and vomiting but lower incidences of nausea and drowsiness. : All side effects characterizing the opioids were related to μ-opioid receptor stimulation, although the present study findings highlight differences in the frequency of specific side effects among the opioids. These results provide objective insights that can guide opioid switching in response to adverse effects.
在姑息治疗中有多种基于阿片类药物的治疗方法,每种方法都有不同的副作用特征。当出现不良事件时,更换阿片类药物有助于维持有效的疼痛管理。然而,由于临床证据有限,目前尚无关于阿片类药物更换的全面指南。本研究使用了副作用资源(SIDER)数据库,该数据库汇总了来自临床试验和药品说明书的不良事件数据,以分析日本姑息治疗中五种常用“强阿片类药物”的副作用,即吗啡、芬太尼、羟考酮、氢吗啡酮和曲马多。:从马克斯·德尔布吕克分子医学中心开发的SIDER 4.1中提取了每种阿片类药物的不良事件名称和发生率数据。进行了聚类分析和主成分分析以解释数据。:阿片类药物的主要副作用是恶心、呕吐、便秘和嗜睡。芬太尼与恶心和呕吐的关联更频繁,但与便秘和嗜睡的关联较少。曲马多引起恶心的频率相对较高,引起便秘的频率较低。羟考酮与嗜睡显著相关,而吗啡经常与便秘和嗜睡相关。氢吗啡酮与便秘和呕吐的发生率较高,但恶心和嗜睡的发生率较低。:尽管本研究结果突出了阿片类药物之间特定副作用频率的差异,但所有表征阿片类药物的副作用都与μ-阿片受体刺激有关。这些结果提供了客观的见解,可指导针对不良反应的阿片类药物更换。